During the past decade, Reid Physician Associates conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Reid Physician Associates" #1 sponsor was "Amgen" with 3 trials, followed by "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "InCarda Therapeutics, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reid Physician Associates" #1 collaborator was "Colorado Prevention Center" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Reid Physician Associates" are "Heart Failure" (2 trials), "Myocardial Infarction" (2 trials), "ASCVD" (1 trials), "Acute Myocardial Infarction" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Reid Physician Associates" in a lesser frequency.

Most popular intervention types in "Reid Physician Associates" are "Drug" (6 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Apixaban 2.5 MG" (1 trials), "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Reid Physician Associates" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Reid Physician Associates". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Reid Physician Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Reid Physician Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".